Healthcare provider profile · identity verified

Hirendra J Dave, MD

Family Practice · NEW ROCHELLE, NY · NPI 1417949421

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	306	98
Atorvastatin Calcium	Atorvastatin Calcium	255	71
Amlodipine Besylate	Amlodipine Besylate	254	61
Levothyroxine Sodium	Levothyroxine Sodium	234	54
Prednisone	Prednisone	147	90
Famotidine	Famotidine	140	38
Furosemide	Furosemide	136	34
Metoprolol Succinate	Metoprolol Succinate	134	38
Pantoprazole Sodium	Pantoprazole Sodium	130	49
Eliquis	Apixaban	124	17
Losartan Potassium	Losartan Potassium	103	30
Cefuroxime	Cefuroxime Axetil	102	72
Azithromycin	Azithromycin	98	70
Escitalopram Oxalate	Escitalopram Oxalate	86	18
Metformin Hcl	Metformin Hcl	85	32
Montelukast Sodium	Montelukast Sodium	80	24
Nebivolol Hcl	Nebivolol Hcl	77	24
Tradjenta	Linagliptin	76	19
Gabapentin	Gabapentin	75	19
Simvastatin	Simvastatin	72	13
Hydrochlorothiazide	Hydrochlorothiazide	70	17
Fenofibrate	Fenofibrate	65	26
Lisinopril	Lisinopril	65	13
Allopurinol	Allopurinol	64	16
Carvedilol	Carvedilol	63	15
Clopidogrel	Clopidogrel Bisulfate	62	13
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	58	28
Mounjaro	Tirzepatide	53	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	52	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	52	20
Januvia	Sitagliptin Phosphate	51	suppressed
Omeprazole	Omeprazole	51	16
Janumet	Sitagliptin Phos/Metformin Hcl	48	13
Naproxen	Naproxen	48	28
Tamsulosin Hcl	Tamsulosin Hcl	48	12
Glimepiride	Glimepiride	44	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	43	14
Synthroid	Levothyroxine Sodium	43	suppressed
Telmisartan	Telmisartan	39	11
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	38	20
Metoprolol Tartrate	Metoprolol Tartrate	38	suppressed
Mupirocin	Mupirocin	38	17
Meclizine Hcl	Meclizine Hcl	35	21
Atenolol	Atenolol	33	suppressed
Memantine Hcl	Memantine Hcl	33	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	33	13
Albuterol Sulfate Hfa	Albuterol Sulfate	32	12
Lactulose	Lactulose	32	15
Jardiance	Empagliflozin	31	suppressed
Meloxicam	Meloxicam	29	14
Ondansetron Hcl	Ondansetron Hcl	28	21
Spironolactone	Spironolactone	28	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	26	suppressed
Farxiga	Dapagliflozin Propanediol	25	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	25	suppressed
Finasteride	Finasteride	24	suppressed
Hydralazine Hcl	Hydralazine Hcl	24	suppressed
Levetiracetam	Levetiracetam	24	suppressed
Enalapril Maleate	Enalapril Maleate	23	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	23	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	22	14
Glipizide	Glipizide	22	suppressed
Trazodone Hcl	Trazodone Hcl	22	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	21	13
Zolpidem Tartrate	Zolpidem Tartrate	21	suppressed
Jentadueto	Linagliptin/Metformin Hcl	20	suppressed
Ammonium Lactate	Ammonium Lactate	19	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	14
Cephalexin	Cephalexin	19	17
Clonazepam	Clonazepam	19	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	18	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	17	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Metformin Hcl Er	Metformin Hcl	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	16
Soliqua 100-33	Insulin Glargine/Lixisenatide	17	suppressed
Torsemide	Torsemide	17	suppressed
Clobetasol Propionate	Clobetasol Propionate	16	suppressed
Fluticasone Propionate	Fluticasone Propionate	16	suppressed
Livalo	Pitavastatin Calcium	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	12
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Clonidine	Clonidine	15	suppressed
Duloxetine Hcl	Duloxetine Hcl	15	suppressed
Ozempic	Semaglutide	15	suppressed
Potassium Chloride	Potassium Chloride	15	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	15	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Fluconazole	Fluconazole	14	12
Glyxambi	Empagliflozin/Linagliptin	14	suppressed
Metronidazole	Metronidazole	14	14
Carbidopa-Levodopa Er	Carbidopa/Levodopa	13	suppressed
Colchicine	Colchicine	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	13	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	13	12
Ramipril	Ramipril	13	suppressed
Synjardy	Empagliflozin/Metformin Hcl	13	suppressed
Valsartan	Valsartan	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	11
Haloperidol	Haloperidol	12	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	12	suppressed
Theophylline Er	Theophylline Anhydrous	12	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Praluent Pen	Alirocumab	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error